Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 7 studies | 22% ± 5% | |
endothelial cell | 6 studies | 22% ± 6% | |
epithelial cell | 5 studies | 23% ± 5% | |
astrocyte | 4 studies | 29% ± 6% | |
oligodendrocyte precursor cell | 4 studies | 23% ± 4% | |
ciliated cell | 3 studies | 18% ± 3% | |
GABAergic neuron | 3 studies | 35% ± 5% | |
glutamatergic neuron | 3 studies | 45% ± 9% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 5 studies | 32% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 4420.71 | 21 / 21 | 100% | 13.96 | 504 / 504 |
esophagus | 100% | 4282.88 | 1445 / 1445 | 100% | 16.12 | 183 / 183 |
kidney | 100% | 3360.29 | 89 / 89 | 100% | 17.21 | 901 / 901 |
prostate | 100% | 4124.92 | 245 / 245 | 100% | 17.49 | 502 / 502 |
skin | 100% | 4329.08 | 1809 / 1809 | 100% | 16.59 | 472 / 472 |
stomach | 100% | 3068.38 | 359 / 359 | 100% | 14.13 | 286 / 286 |
breast | 100% | 3503.10 | 459 / 459 | 100% | 20.95 | 1117 / 1118 |
lung | 100% | 3272.39 | 577 / 578 | 100% | 15.47 | 1155 / 1155 |
intestine | 100% | 4296.38 | 966 / 966 | 100% | 14.12 | 525 / 527 |
uterus | 100% | 3977.11 | 170 / 170 | 100% | 14.86 | 457 / 459 |
brain | 100% | 2835.42 | 2629 / 2642 | 100% | 15.57 | 705 / 705 |
thymus | 100% | 4546.22 | 653 / 653 | 100% | 18.11 | 602 / 605 |
ovary | 100% | 3816.49 | 180 / 180 | 99% | 13.18 | 427 / 430 |
adrenal gland | 100% | 3923.91 | 258 / 258 | 99% | 14.49 | 227 / 230 |
pancreas | 99% | 1898.07 | 326 / 328 | 99% | 12.63 | 176 / 178 |
liver | 100% | 1995.83 | 226 / 226 | 97% | 9.50 | 395 / 406 |
adipose | 100% | 3334.26 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 14.02 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 10.15 | 29 / 29 |
muscle | 100% | 4336.52 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 3808.49 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 16.05 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 8.40 | 1 / 1 |
blood vessel | 100% | 3447.77 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 3559.74 | 854 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 92% | 1786.47 | 855 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0000209 | Biological process | protein polyubiquitination |
GO_0006511 | Biological process | ubiquitin-dependent protein catabolic process |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
Gene name | UBE3B |
Protein name | Ubiquitin-protein ligase E3B (EC 2.3.2.26) (HECT-type ubiquitin transferase E3B) Ubiquitin protein ligase E3B |
Synonyms | |
Description | FUNCTION: E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates. . |
Accessions | Q7Z3V4 F5H6D6 ENST00000449510.6 [Q7Z3V4-2] B9EK57 ENST00000537063.1 ENST00000605142.1 ENST00000434735.6 [Q7Z3V4-1] ENST00000536398.5 [Q7Z3V4-3] ENST00000539599.5 S4R3H8 ENST00000340074.9 [Q7Z3V4-3] F5H5T5 ENST00000540230.5 [Q7Z3V4-3] ENST00000342494.8 [Q7Z3V4-1] |